Genetic disorders and periodontal health: A literature review

Medical Science Monitor

Volumn 15, Issue 8, 2009, Pages

  Pizzo, Giuseppe ^a   Re, Daniela Lo ^a   Piscopo, Maria Ruth ^a   Pizzo, Ignazio ^a   Giuliana, Giovanna ^a  

^a UNIVERSITY OF PALERMO   (Italy)

Author keywords

Diagnosis; Genetic disorders; Periodontal disease; Treatment

Indexed keywords

AMOXICILLIN; COLLAGEN; METRONIDAZOLE; NONSTEROID ANTIINFLAMMATORY AGENT; PARATHYROID HORMONE[1-34];

BONE MARROW DEPRESSION; CATALASE DEFICIENCY; CHEDIAK HIGASHI SYNDROME; CHROMOSOME ABERRATION; CONGENITAL DISORDER OF GLYCOSYLATION TYPE 2C; CONNECTIVE TISSUE; DENTAL HEALTH; DIET THERAPY; DISEASE ASSOCIATION; DOWN SYNDROME; EHLERS DANLOS SYNDROME; FIBROMATOSIS; GENETIC DISORDER; GINGIVA OVERGROWTH; GLYCOGEN STORAGE DISEASE; HUMAN; HYPOPHOSPHATASIA; LEUKOCYTE ADHESION DEFICIENCY; MANNOSIDOSIS; METABOLIC DISORDER; MOUTH HYGIENE; MUCOPOLYSACCHARIDOSIS; NEUTROPENIA; PAPILLON LEFEVRE SYNDROME; PERIODONTAL DISEASE; PERIODONTITIS; REVIEW; SKIN DISEASE; TISSUE METABOLISM; TREATMENT RESPONSE;

CHROMOSOME ABERRATIONS; GENETIC DISEASES, INBORN; HEALTH; HUMANS; METABOLIC DISEASES; PERIODONTAL DISEASES; SKIN DISEASES;

EID: 68449096387     PISSN: 12341010     EISSN: 16433750     Source Type: Journal    
DOI: None     Document Type: Review

References (99)

1. Nanci A, Bosshardt DD: Structure of periodontal tissues in health and disease. Periodontol 2000, 2006; 40: 11-28
2. Socransky SS, Haffajee AD: The bacterial etiology of destructive periodontal disease: current concepts. J Periodontol, 1992; 63: 322-331
3. Kinane DF, Peterson M, Stathopoulou PG: Environmental and other modifying factors of the periodontal diseases. Periodontol 2000, 2006; 40: 107-119
4. Hart TC, Atkinson JC: Mendelian forms of periodontitis. Periodontology 2000, 2007; 45: 95-112
5. Armitage GC: Development of a classification system for periodontal diseases and conditions. Ann Periodontol, 1999; 4: 1-6
6. Beighton P, De Paepe A, Steinmann B et al: Ehlers-Danlos syndromes: Revised Nosology, Villefranche, 1997. Am J Med Genet, 1998; 77: 31-37 (Pubitemid 28176360)
7. Pyeritz RE: Ehlers-Danlos syndrome. In: Goldman L, Bennett JC (eds.), Cecil Textbook of Medicine. Philadelphia: W.B. Saunders, 2000; 1119-1120
8. De Paepe A, Malfait F: Bleeding and bruising in patients with Ehlers-Danlos syndrome and other collagen vascular disorders. Br J Haematol, 2004; 127: 491-500 (Pubitemid 39627173)
9. De Coster PJ, Martens LC, De Paepe A: Oral health in prevalent types of Ehlers-Danlos syndromes. J Oral Pathol Med, 2005; 34: 298-307
10. Perez LA, Al-Shammari KF, Giannobile WV, Wang HL: Treatment of periodontal disease in a patient with Ehlers-Danlos syndrome. A case report and literature review. J Periodontol, 2002; 73: 564-570 (Pubitemid 34546410)
11. Khocht A, Calem B, Deasy M: Use of anti-inflammatory medications in managing atypical gingivitis associated with hypermobile Ehlers-Danlos syndrome: A case report. J Periodontol, 2004; 75: 1547-1552 (Pubitemid 40012340)
12. Letourneau Y, Perusse R, Buithieu H: Oral manifestations in Ehlers-Danlos syndrome. J Can Dent Assoc, 2001; 67: 330-334
13. Michalski JC, Klein A: Glycoprotein lysosomal storage disorders: alpha-and beta-mannosidosis, fucosidosis and alpha-N-acetylgalactosaminidase deficiency. Biochim Biophys Acta, 1999; 1455: 69-84
14. Lyons MJ, Wood T, Espinoza L et al: Early onset alpha-mannosidosis with slow progression in three Hispanic males. Dev Med Child Neurol, 2007; 49: 854-857 (Pubitemid 350020448)
15. Thomas HT: Disorders of glycoprotein degradation: a-mannosidosis, b-mannosidosis, fucosidosis and sialidosis. In: Scriver CH, Beaudet AL, Sly WS, Valle D (eds.), The Metabolic and Molecular Bases of Inherited Disease. New York: McGraw-Hill, 2001; 3507-3533
16. Applegarth DA, Toone JR, Lowry RB: Incidence of inborn errors of metabolism in British Columbia, 1969-1996. Pediatrics, 2000; 105: 109-205
17. Nelson J, Crowhurst J, Carey B, Greed L: Incidence of the Mucopolysaccharidoses in Western Australia. Am J Med Genet A, 2003; 123A: 310-313
18. Baehner F, Schmiedeskamp C, Krummenauer F et al: Cumulative incidence rates of the mucopolysaccharidoses in Germany. J Inherit Metab Dis, 2005; 28: 1011-1017 (Pubitemid 43168938)
19. Ashworth JL, Biswas S, Wraith E, Lloyd IC: Mucopolysaccharidoses and the eye. Sur Ophthalmol, 2006; 51: 1-17
20. Winik B, Boente M, Asial R: Juvenile hyaline fibromatosis ultrastructural study. Am J Dermatopathol, 1998; 20: 373-378 (Pubitemid 28363620)
21. Yayli S, Uncu S, Alpay K et al: A case of juvenile hyaline fibromatosis. J Dermatol, 2006; 33: 260-264
22. Thomas JE, Moossavi M, Mehregan DR, McFalda WL: Juvenile hyaline fibromatosis: a case report and review of the literature. Int J Dermatol, 2004; 43: 785-789 (Pubitemid 39529935)
23. Dhingra M, Amladi S, Savant S, Nayak C: Juvenile hyaline fibromatosis and infantile systemic hyalinosis: divergent expressions of the same genetic defect? Indian J Dermatol Venereol Leprol, 2008; 74: 371-374
24. Uslu H, Bal N, Guzeldemir E, Pektas ZO: Three siblings with juvenile hyaline fibromatosis. J Oral Pathol Med, 2007; 36: 123-125 (Pubitemid 46089315)
25. Breier F, Fang-Kircher S, Wolff K, Jurecka W: Juvenile hyaline fibromatosis: impaired collagen metabolism in human skin fibroblasts. Arch Dis Child, 1997; 77: 436-440 (Pubitemid 27521529)
26. Rahman N, Dunstan M, Teare MD et al: The gene for juvenile hyaline fibromatosis maps to chromosome 4q21. Am J Hum Genet, 2002; 71: 975-980 (Pubitemid 135750530)
27. Larralde M, Santos-Muñoz A, Calb I, Magariños C: Juvenile hyaline fibromatosis. Pediatr Dermatol, 2001; 18: 400-402
28. Keser G, Karabulut B, Oksel F et al: Two siblings with juvenile hyaline fibromatosis: case reports and review of the literature. Clin Rheumatol, 1999; 18: 248-252 (Pubitemid 29284726)
29. Kara C, Demir T, Tezel A: Effectiveness of periodontal therapies on the treatment of different aetiological factors induced gingival overgrowth in puberty. Int J Dent Hyg, 2007; 5: 211-217
30. Howe LC, Palmer RM: Periodontal and restorative treatment in a patient with familial gingival fibromatosis: a case report. Quintessence Int, 1991; 22: 871-872
31. Hart TC, Hart PS, Michalec MD et al: Localization of a gene for prepuberal periodontitis to chromosome 11q14 and identification of a cathepsin C gene mutation. J Med Genet, 2000; 37: 95-101
32. de Haar SF, Jansen DC, Schoenmaker T et al: Loss-of-function mutations in cathepsin C in two families with Papillon-Lefèvre Syndrome are associated with deficiency of serine proteinases in PMNs. Hum Mutat, 2004; 23: 524
33. Ryu OH, Choi SJ, Linares AMG et al: Gingival epithelial cell expression of macrophage inflammatory protein-1alpha induced by interleukin-1 beta and lipopolysaccharide. J Periodontol, 2007; 78: 1627-1634
34. Meade JL, de Wynter EA, Brett P et al: A family with Papillon- Lefèvre Syndrome reveals a requirement for cathepsin C in granzyme B activation and NK cell cytolytic activity. Blood, 2006; 107: 3665-3668
35. D'Angelo, Margiotta V, Ammatuna P, Sammartano F: Treatment of prepubertal periodontitis. A case report and discussion. J Clin Periodontol, 1992; 19: 214-219
36. Schacher B, Baron F, Ludwig B et al: Periodontal therapy in siblings with Papillon-Lefèvre syndrome and tinea capitis: a report of two cases. J Clin Periodontol, 2006; 33: 829-836 (Pubitemid 44511034)
37. Pacheco JJ, Coelho C, Salazar F et al: Treatment of Papillon- Lefèvre Syndrome periodontitis. J Clin Periodontol, 2002; 29: 370-374
38. Haim S, Munk J: Keratosis palmo-plantaris congenita, with periodontosis, arachnodactyly, and peculiar deformity of the terminal phalanges. Br J Dermatol, 1965; 77: 42-54
39. Noack B, Görgens H, Schacher B et al: Functional Cathepsin C mutations cause different Papillon-Lefèvre syndrome phenotypes. J Clin Periodontol, 2008; 35: 311-316
40. De Vree H, Steenackers K, De Boever JA: Periodontal treatment of rapid progressive periodontitis in 2 siblings with Papillon-Lefèvre syndrome: 15-years follow-up. J Clin Periodontol, 2000; 27: 354-360
41. Tinanoff N, Tempro P, Maderazo EG: Dental treatment of Papillon-Lefèvre Syndrome: 15 year follow-up. J Clin Periodontol, 1995; 22: 609-612
42. Wiebe CB, Häkkinen L, Putkins EE et al: Successful periodontal maintenance of a case with Papillon-Lefèvre syndrome: 12-years follow-up and review of the literature. J Periodontol, 2001; 72: 824-830
43. Ullbro C, Brown A, Twetman S: Preventive periodontal regimen in Papillon-Lefèvre syndrome. Pediatric Dent, 2005; 27: 226-232
44. Eickholz P, Kugel B, Pohl S et al: Combined mechanical and antibiotic periodontal therapy in a case of Papillon-Lefèvre Syndrome. J Periodontol, 2001; 72: 542-549 (Pubitemid 32524489)
45. Lux CJ, Kugel B, Komposch G et al: Orthodontic treatment in a patient with Papillon-Lefevre Syndrome. J Periodontol, 2005; 76: 149-157
46. Ullbro C, Twetman S: Review paper: Dental treatment for patients with Papillon-Lefèvre syndrome (PLS). Eur Arch Paediatr Dent, 2007; 8(Suppl.1): 4-11
47. van Schaftingen E, Gerin I: The glucose-6-phosphatase system. Biochem J, 2002; 362: 513-532
48. Annabi B, Hiraiwa H, Mansfield BC et al: The gene for glycogen-storage disease type 1b maps to chromosome 11q23. Am J Hum Genet, 1998; 62: 400-405 (Pubitemid 28110783)
49. Veiga-da-Cunha M, Gerin I, Van Schaftingen E: How many forms of glycogen storage disease type I? Eur J Pediatr, 2000; 59: 314-318
50. Dellinger TM, Livingston HM, Holder R, Streckfus CF: Glycogen storage disease and von Willebrand's disease implication for dental treatment: dental management of a paediatric patient. Spec Care Dentist, 1998; 18: 243-246
51. Mortellaro C, Garagiola U, Carbone V et al: Unusual oral manifestations and evolution in glycogen storage type Ib. J Craniofac Surg, 2005; 16: 45-52 (Pubitemid 40976055)
52. Bartoli A, Bossù M, Sfasciotti G, Polimeni A: Glycogen Storage Disease type Ib: a paediatric case report. Eur J Paediatr Dent, 2006; 7: 192-198
53. Mornet E. Hypophosphatasia. Orphanet J Rare Dis, 2007; 2: 1-8
54. Whyte MP: Hypophosphatasia and the role of alkaline phosphatase in skeletal mineralization. Endocr Rev, 1994; 15: 439-461 (Pubitemid 24271239)
55. Chapple ILC: Hypophosphatasia: dental aspects and mode of inheritance. J Clin Periodontol, 1993; 20: 615-622
56. Meyle J, Gonzales JR: Influences of systemic diseases on periodontitis in children and adolescents. Periodontol 2000, 2001; 26: 92-112
57. Girschick HJ, Schneider P, Haubitz I et al: Effective NSAID treatment indicates that hyperprostaglandinism is affecting the clinical severity of childhood hypophosphatasia. Orphanet J Rare Dis, 2006; 1: 24
58. Girschick HJ, Mornet E, Beer M et al: Chronic multifocal non-bacterial osteomyelitis in hypophosphatasia mimicking malignancy. BMC Pediatr, 2007; 7: 3 (Pubitemid 46242965)
59. Whyte MP, Mumm S, Deal C: Adult hypophosphatasia treated with teriparatide. J Clin Endocrinol Metab, 2007; 92: 1203-1208
60. Li FQ, Horwitz M: Characterization of mutant neutrophil elastase in severe congenital neutropenia. J Biol Chem, 2001; 276: 14230-14241 (Pubitemid 37391810)
61. Person RE, Li FQ, Duan Z et al: Mutations in proto-oncogene GFI1 cause human neutropenia and target ELA2. Nat Genet, 2003; 34: 308-312 (Pubitemid 36792864)
62. Duan Z, Horwitz M: Gfi-1 takes center stage in hematopoietic stem cells. Trends Mol Med, 2005; 11: 49-52 (Pubitemid 40193481)
63. Klein C, Grudzien M, Appaswamy G et al: HAX1 deficiency causes autosomal recessive severe congenital neutropenia (Kostmann disease). Nat Genet, 2007; 39: 86-92
64. Ancliff PJ, Gale RE, Liesner R et al: Mutations in the ELA2 gene encoding neutrophil elastase are present in most patients with sporadic severe congenital neutropenia but only in some patients with the familial form of the disease. Blood, 2001; 98: 2645-2650
65. Carlsson G, Aprikyan AA, Ericson KG et al: Neutrophil elastase and granulocyte colony stimulating factor receptor mutation analyses and leukemia evolution in severe congenital neutropenia patients belonging to the original Kostmann family in northern Sweden. Haematologica, 2006; 91: 589-595 (Pubitemid 43799452)
66. Zeidler C, Schwinzer B, Welte K: Congenital neutropenias. Rev Clin Exp Hematol, 2003; 7: 72-83
67. Horwitz MS, Duan Z, Korkmaz B et al: Neutrophil elastase in cyclic and severe congenital neutropenia. Blood, 2007; 109: 1817-1824 (Pubitemid 46348175)
68. Horwitz MS, Benson KF, Person RE et al: Mutations in ELA2, encoding neutrophil elastase, define a 21-day biological clock in cyclic haematopoiesis. Nat Genet, 1999; 23: 433-443
69. Zaromb A, Chamberlain D, Schoor R et al: Periodontitis as a manifestation of chronic benign neutropenia. J Periodontol, 2006; 77: 1921-1926 (Pubitemid 44794847)
70. Lange RD, Jones JB: Cyclic neutropenia. Review of clinical manifestations and management. Am J Pediatr Hematol Oncol, 1981; 3: 363-367
71. Rylander H, Ericsson I: Manifestations and treatment of periodontal disease in a patient suffering from cyclic neutropenia. J Clin Periodontol, 1981; 8: 77-87 (Pubitemid 11155665)
72. Deasy MJ, Vogel RI, Macedo-Sobrinho B et al: Familial benign chronic neutropenia associated with periodontal disease. A case report. J Periodontol, 1980; 51: 206-210 (Pubitemid 10088852)
73. Buduneli N, Cogulu D, Kardesler L, Kütükçüler N: Dental findings and treatment in consanguinity associated congenital chronic familial neutropenia. J Clin Pediatr Dent, 2006; 31: 123-126
74. Bush FH: Familial benign chronic neutropenia in a Danish family. Ugeskr Laeger, 1990; 152: 2565-2566
75. Deas DE, Mackey SA, McDonnell HT: Systemic diseases and periodontitis: manifestations of neutrophil dysfunction. Periodontol 2000, 2003; 32: 82-104
76. Brown CJ: Dyskeratosis congenita: report of a case. Int J Paediatr Dent, 2000; 10: 328-334
77. Nagle DL, Karim MA, Woolf EA et al: Identification and mutation analysis of the complete gene for Chediak-Higashi syndrome. Nat Genet, 1996; 14: 307-311 (Pubitemid 126449765)
78. Charette SJ, Cosson P: A LYST/beige homolog is involved in biogenesis of Dictyostelium secretory lysosomes. J Cell Sci, 2007; 120: 2338-2343
79. Rezaei N, Farhoudi A, Ramyar A et al: Congenital neutropenia and primary immunodeficiency disorders: a survey of 26 Iranian patients. J Pediatr Hematol Oncol, 2005; 27: 351-356 (Pubitemid 41077022)
80. Delcourt-Debruyne EM, Boutigny HR, Hildebrand HF: Features of severe periodontal disease in a teenager with Chediak-Higashi syndrome. J Periodontol, 2000; 71: 816-824
81. Shibutani T, Gen K, Shibata M et al: Long-term follow-up of periodontitis in a patient with Chediak-Higashi syndrome. A case report. J Periodontol, 2000; 71: 1024-1028
82. Cox DP, Weathers DR: Leukocyte adhesion deficiency type 1: an important consideration in the clinical differential diagnosis of prepubertal periodontitis. A case report and review of the literature. Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 2008; 105: 86-90
83. Arnaout MA, Dana N, Gupta SK et al: Point mutations impairing cell surface expression of the common beta subunit (CD 18) in a patient with leukocyte adhesion molecule (Leu-CAM) deficiency. J Clin Invest, 1990; 85: 977-981 (Pubitemid 20087506)
84. Majorana A, Notarangelo LD, Savoldi E et al: Leukocyte adhesion deficiency in a child with severe oral involvement. Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 1999; 87: 691-694
85. Etzioni A, Tonetti M: Leukocyte adhesion deficiency II-from A to almost Z. Immunol Rev, 2000; 178: 138-147 (Pubitemid 32095227)
86. Ishikawa HO, Higashi S, Ayukawa T et al: Notch deficiency implicated in the pathogenesis of congenital disorder of glycosylation IIc. Proc Natl Acad Sci USA, 2005; 102: 18532-18537 (Pubitemid 43011260)
87. Etzioni A, Frydman M, Pollack S et al: Brief report: recurrent severe infections caused by a novel leucocyte adhesion deficiency. N Engl J Med, 1992; 327: 1789-1792
88. Lubke T, Marquardt T, Von Figura K, Korner C: A new type of carbohydrate-deficient glycoprotein syndrome due to a decreased import of GDP-fucose into the golgi. J Biol Chem, 1999; 274: 25986-25989 (Pubitemid 129520017)
89. Etzioni A, Sturla L, Antonellis A et al: Leukocyte adhesion deficiency (LAD) type II/carbohydrate deficient glycoprotein (CDG) IIc founder effect and genotype/ phenotype correlation. Am J Med Genet, 2002; 110: 131-135
90. Hakki SS, Aprikyan AA, Yildirim S et al: Periodontal status in two siblings with severe congenital neutropenia: diagnosis and mutational analysis of the cases. J Periodontol, 2005; 76: 837-844 (Pubitemid 40852397)
91. Carlsson G, Wahlin YB, Johansson A et al: Periodontal disease in patients from the original Kostmann family with severe congenital neutropenia. J Periodontol, 2006; 77: 744-751 (Pubitemid 44725064)
92. Lejeune J, Gautier M, Turpin R: Etude de chromosomes somatique de neuf enfant Mongolien. Compt rend Acad Sci 1959; 248: 1721-1722
93. Shapira J, Stabholz A, Schurr D et al: Caries levels, Streptococcus mutans counts, salivary pH and periodontal treatment needs of adult Down syndrome patients. Spec Care Dentistry, 1991; 11: 248-251
94. Saxén L, Aula S, Westermarck T: Periodontal disease associated with Down's syndrome: an orthopantomographic evaluation. J Periodontol, 1977; 48: 337-340 (Pubitemid 8126318)
95. Barr-Agholme M, Dahllof G, Modeer T et al: Periodontal conditions and salivary immunoglobulins in individuals with Down's syndrome. J Periodontol, 1998; 69: 1119-1123 (Pubitemid 128523622)
96. Nowak A: Primary preventive dentistry for children. Update Pediatr Dent, 1990; 3: 1-4, 6-7
97. Fardal O, Turnbull RS: A review of literature on the use of chlorhexidine in dentistry. J Am Dent Assoc, 1986; 112: 863-869
98. Boughman JA, Halloran SL, Roulston D et al: An autosomal-dominant form of juvenile periodontitis: its localization to chromosome 4 and linkage to dentinogenesis imperfecta and Gc. J Craniofac Genet Dev Biol, 1986; 6: 341-350
99. Dong J, Gu T, Jeffords L, MacDougall M: Dentin phosphoprotein compound mutation in dentin sialophosphoprotein causes dentinogenesis imperfect type III. Am J Med Genet Assoc, 2005; 132: 305-309 (Pubitemid 40076236)